Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$4.87 - $7.08 $49,187 - $71,508
-10,100 Reduced 6.73%
139,900 $681,000
Q1 2019

May 13, 2019

BUY
$5.76 - $8.95 $859,392 - $1.34 Million
149,200 Added 18650.0%
150,000 $0
Q3 2018

Nov 13, 2018

BUY
$4.65 - $7.95 $3,720 - $6,360
800 New
800 $6,000

Others Institutions Holding CRBP

About Corbus Pharmaceuticals Holdings, Inc.


  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $724M
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Sculptor Capital LP Portfolio

Follow Sculptor Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Sculptor Capital LP with notifications on news.